What is Hyperfine, Inc.'s market cap?

Hyperfine, Inc. (HYPR) has a market capitalization of $111.7M and trades on NASDAQ.

What is Hyperfine, Inc.'s revenue and profitability?

Hyperfine, Inc. generated $15.3M in trailing twelve-month revenue with a net loss of $34.8M, representing a net margin of -226.9%. Gross margin stands at 51.2%, with free cash flow of -$28.7M. These figures are based on the Q1 2026 filing.

Who are Hyperfine, Inc.'s competitors?

Hyperfine, Inc.'s key competitors include General Electric, Philips, QT Imaging Holdings, Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Who does Hyperfine, Inc. partner with?

Hyperfine, Inc.'s notable partners include Benchmark Electronics, Inc., Bill & Melinda Gates Foundation, GV (Google Ventures).

What subsidiaries does Hyperfine, Inc. have?

Hyperfine, Inc.'s subsidiaries include Liminal Sciences, Inc., Hyperfine Operations, Inc..

Where is Hyperfine, Inc. headquartered?

Hyperfine, Inc. is headquartered in United States of America and employs approximately 131 people. It has been publicly traded since 2021.

Hyperfine, Inc.

HYPR

Hyperfine is a health technology company focused on revolutionizing patient care through the development of accessible, AI-powered portable ultra-low-field magnetic resonance imaging.

Market cap

$111.68M+83.0%

Revenue$15.3M+30.7%

Net income-$34.8M+13.7%

Free cash flow-$28.7M+20.9%

EPS (diluted)-$0.40+25.9%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 12, 2026

Revenue$3.9MBeat by $363.0K EPS-$0.09In line

Read the full report

Next report

Aug 12, 2026 (in a month)

Revenue estimate$4.1M

EPS estimate-$0.09

Financials

Q1 2026

Income statement

See full

Revenue$3.9M+82.6%

Gross profit$2.0M+124%

Operating income-$8.6M+21.5%

Net income-$8.6M+8.4%

EPS (diluted)-$0.09+25.0%

Balance sheet

See full

Cash & equivalents$40.8M+23.2%

Total debt$13.4M+4,977%

Total equity$34.4M-20.3%

Total assets$60.3M+13.0%

Cash flow

See full

Operating cash flow-$9.0M+2.6%

CapEx$242.0K-48.7%

Free cash flow-$9.3M+4.8%

Valuation & ratios

Valuation

See full

Market cap$111.68M+83.0%

Enterprise value$84.25M+145%

P/S7.3×+1.8×

Profitability

See full

Gross margin51.2%+5.0pp

Operating margin-226.6%-63.4pp

Net margin-226.9%-57.5pp

FCF margin-187%-52.9pp

Returns & leverage

See full

Return on equity-89.8%+42.9pp

Debt / equity0.4×+0.4×

Current ratio5.5×-0.5×

Segments

By geography

See full

Non Us$726.0K-32.4%

By product

See full

Service$646.0K+5.0%

Competitors

By market cap

General Electric$374.60B+41.3%

GE HealthCare Technologies$29.4B-13.8%

Philips$26.5B+20.1%

RadNet$5.2B+25.1%

iRadimed$1.3B+67.0%

Lumexa Imaging Holdings, Inc. $1.2B—

Hyperfine, Inc.$111.7M+87.5%

QT Imaging Holdings, Inc.$51.1M—

By revenue growth

QT Imaging Holdings, Inc.+259%

Hyperfine, Inc.+30.7%

General Electric+21.8%

iRadimed+14.8%

RadNet+14.7%

GE HealthCare Technologies+6.0%

By net margin

iRadimed27.36%+1.0pp

General Electric17.86%+0.2pp

GE HealthCare Technologies9.1%-1.9pp

RadNet-0.662%+1.1pp

QT Imaging Holdings, Inc.-58.94%+250pp

Hyperfine, Inc.-226.88%+117pp

Profile

Hyperfine is a health technology company focused on revolutionizing patient care through the development of accessible, AI-powered portable ultra-low-field magnetic resonance imaging. Its core value proposition centers on the Swoop system, which enables high-quality brain imaging at the point of care, eliminating the need for specialized facilities and complex patient transport. The company leverages deep learning algorithms to enhance image quality and diagnostic utility in diverse clinical settings.

Competitive position

First-mover in AI-powered portable ultra-low-field MRI with a significant proprietary patent portfolio and FDA-cleared technology.

GeographiesUnited States, Canada, European Union, United Kingdom, Australia, New Zealand, India

Customer segmentsHospitals, Specialized Medical Practices, Public and Private Health Systems

Business modelCapital Equipment Sales, Subscription SaaS, Service and Support Agreements

SuppliersSpecialized magnet manufacturers, Semiconductor suppliers (FPGAs, CPUs), Contract manufacturers, Molded plastics suppliers

CustomersRadiologists, Neurologists, Intensivists, Hospital Administrators, Teleradiology service providers

CountryUnited States of America

Listed2021

Employees131.0

CEOMaria Degois Sainz

SectorHealthcare

IndustryMedical - Devices

Websitehyperfine.io

FilingsSEC EDGAR

Ask your AI about Hyperfine, Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Hyperfine, Inc.'s market cap?: Hyperfine, Inc. (HYPR) has a market capitalization of $111.7M and trades on NASDAQ.
What is Hyperfine, Inc.'s revenue and profitability?: Hyperfine, Inc. generated $15.3M in trailing twelve-month revenue with a net loss of $34.8M, representing a net margin of -226.9%. Gross margin stands at 51.2%, with free cash flow of -$28.7M. These figures are based on the Q1 2026 filing.
Who are Hyperfine, Inc.'s competitors?: Hyperfine, Inc.'s key competitors include General Electric, Philips, QT Imaging Holdings, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does Hyperfine, Inc. partner with?: Hyperfine, Inc.'s notable partners include Benchmark Electronics, Inc., Bill & Melinda Gates Foundation, GV (Google Ventures).
What subsidiaries does Hyperfine, Inc. have?: Hyperfine, Inc.'s subsidiaries include Liminal Sciences, Inc., Hyperfine Operations, Inc..
Where is Hyperfine, Inc. headquartered?: Hyperfine, Inc. is headquartered in United States of America and employs approximately 131 people. It has been publicly traded since 2021.